On November 6, 2024, Mark Vachon, associated with bluebird bio, Inc. [BLUE], was granted 24,900 shares of common stock at no cost. This transaction, which was completed on the same day, increased Vachon's direct holdings in the company to a total of 49,941 shares. The grant is part of the company's stock-based compensation program and reflects a direct ownership interest in the securities.

On November 6, 2024, Mark Vachon, associated with bluebird bio, Inc. [BLUE], was granted 24,900 shares of common stock at no cost. This transaction, which was completed on the same day, increased Vachon's direct holdings in the company to a total of 49,941 shares. The grant is part of the company's stock-based compensation program and reflects a direct ownership interest in the securities.